Host Julia Cartwright explores how GLP-1 weight loss drugs are revolutionizing obstructive sleep apnea treatment, following tirzepatide's groundbreaking FDA approval. From clinical trial results to biological mechanisms and access barriers, this series examines whether these drugs offer real hope beyond the CPAP machine for millions of Americans. For more content like this, visit QuietPlease.ai
Copyright 2025 Inception Point Ai
Sign up to track rankings and reviews from Spotify, Apple Podcasts and more.